Following this month's FDA approval of Eli Lilly’s amyloid-busting antibody Kisunla (donanemab), the Alzheimer’s disease ...

The dog days of summer might be in full swing, but for flu vaccine makers, its a busy time prepping for this fall's influenza ...

After a rocky road to approval and two amendments to the original pact, Akebia Therapeutics and CSL Vifor have terminated ...

In surging to the top spot in the market cap rankings in Europe, Novo Nordisk has been on an extended winning streak. But the ...

CDMO Tergus Pharma plans to merge with MedPharm, a U.K.-based company that specializes in the development of dermatology, ...

Ogilvy Health has added to the roster at its Singapore office, hiring Sofia Beccarelli as associate planning director for the ...

It’s well known that obesity drugs from Novo Nordisk and Eli Lilly are on a high-flying growth trajectory that doesn’t look ...